Maternal health, neonatology and perinatology towards a standardized outcome set for clinical trials in Hemolytic Disease of the Fetus and Newborn (HDFN): preliminary findings from two European advisory boards. [PDF]
Lopriore E +6 more
europepmc +1 more source
In response: Risks of directed blood donations from relatives: A clarification. [PDF]
Kanter MH.
europepmc +1 more source
Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study. [PDF]
Khadka N +9 more
europepmc +1 more source
Characterization of the clinical course of early-onset severe hemolytic disease of the fetus and newborn. [PDF]
Oepkes D +20 more
europepmc +1 more source
Plain Language Summary of Publication: Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM). [PDF]
Tjoa ML +8 more
europepmc +1 more source
Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn. [PDF]
Zhou J +8 more
europepmc +1 more source
Acute hemolytic transfusion reaction mediated by anti-Jk<sup>b</sup> antibody in a pediatric patient with β-thalassemia major: a case report illustrating an anamnestic alloimmune response. [PDF]
Xu J, Chen J.
europepmc +1 more source
Avoidable under-5 mortality from congenital and genetic disorders: a frontier analysis of GBD 2023 identifying intervention targets. [PDF]
Ruan J +8 more
europepmc +1 more source
The Frequency of Severe Hemolytic Disease of the Fetus and Newborn Caused by Red Blood Cell Alloantibodies Undetected at the Antibodies Screening in the First Trimester: A Prospective Study. [PDF]
Dajak S, Cherepnalkovski AP, Odak P.
europepmc +1 more source

